GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Planet 13 Holdings Inc (OTCPK:PLNH) » Definitions » Days Sales Outstanding

Planet 13 Holdings (Planet 13 Holdings) Days Sales Outstanding : 4.80 (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Planet 13 Holdings Days Sales Outstanding?

Planet 13 Holdings's average Accounts Receivable for the three months ended in Dec. 2023 was $1.21 Mil. Planet 13 Holdings's Revenue for the three months ended in Dec. 2023 was $22.97 Mil. Hence, Planet 13 Holdings's Days Sales Outstanding for the three months ended in Dec. 2023 was 4.80.

The historical rank and industry rank for Planet 13 Holdings's Days Sales Outstanding or its related term are showing as below:

PLNH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 1.23   Med: 2.52   Max: 4.71
Current: 4.67

During the past 8 years, Planet 13 Holdings's highest Days Sales Outstanding was 4.71. The lowest was 1.23. And the median was 2.52.

PLNH's Days Sales Outstanding is ranked better than
98.4% of 1001 companies
in the Drug Manufacturers industry
Industry Median: 71.7 vs PLNH: 4.67

Planet 13 Holdings's Days Sales Outstanding increased from Dec. 2022 (4.69) to Dec. 2023 (4.80).


Planet 13 Holdings Days Sales Outstanding Historical Data

The historical data trend for Planet 13 Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Planet 13 Holdings Days Sales Outstanding Chart

Planet 13 Holdings Annual Data
Trend Jun16 Jun17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial 1.23 1.69 2.52 4.44 4.67

Planet 13 Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.69 4.68 4.50 4.68 4.80

Competitive Comparison of Planet 13 Holdings's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Planet 13 Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Planet 13 Holdings's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Planet 13 Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Planet 13 Holdings's Days Sales Outstanding falls into.



Planet 13 Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Planet 13 Holdings's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (1.327 + 1.196) / 2 ) / 98.505*365
=1.2615 / 98.505*365
=4.67

Planet 13 Holdings's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (1.22 + 1.196) / 2 ) / 22.969*365 / 4
=1.208 / 22.969*365 / 4
=4.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Planet 13 Holdings  (OTCPK:PLNH) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Planet 13 Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Planet 13 Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Planet 13 Holdings (Planet 13 Holdings) Business Description

Traded in Other Exchanges
Address
2548 West Desert Inn Road, Las Vegas, NV, USA, 89109
Planet 13 Holdings Inc operates as an integrated cannabis company based in Nevada, with cultivation, production, and dispensary operations in Las Vegas. The company is focused on providing an unparalleled dispensary experience and optimizing cultivation efficiencies through its technology as the vanguard of cannabis.
Executives
Chris Wren officer: VP of Operations 2548 WEST DESERT INN ROAD, SUITE 100, LAS VEGAS NV 89109
Dennis Logan officer: CFO 2548 WEST DESERT INN ROAD, SUITE 100, LAS VEGAS NV 89109
Leighton Koehler officer: General Counsel 2548 WEST DESERT INN ROAD, SUITE 100, LAS VEGAS NV 89109
Larry Scheffler director, 10 percent owner, officer: Co-CEO 2548 WEST DESERT INN ROAD, SUITE 100, LAS VEGAS NV 89109
David Farris officer: VP of Sales & Marketing 2548 WEST DESERT INN ROAD, SUITE 100, LAS VEGAS NV 89109
Adrienne O'neal director 2548 WEST DESERT INN ROAD, SUITE 100, LAS VEGAS NV 89109
William Vargas officer: VP of Finance 2548 WEST DESERT INN ROAD, SUITE 100, LAS VEGAS NV 89109
Robert Groesbeck director, 10 percent owner, officer: Co-CEO 2548 WEST DESERT INN ROAD, SUITE 100, LAS VEGAS NV 89109
Lee Fraser director 4675 W TECO AVE, SUITE 250, LAS VEGAS NV 89118
Todd Hybels officer: VP of Midwestern Operations 2548 WEST DESERT INN ROAD, SUITE 100, LAS VEGAS NV 89109
Michael Lanteri Jennings officer: Pres. of East Coast Operations 2548 WEST DESERT INN ROAD, SUITE 100, LAS VEGAS NV 89109
Michael Harman director 2548 WEST DESERT INN ROAD, SUITE 100, LAS VEGAS NV 89109